返回 Agenda
Session 8: Implementing Metrics - Where are We Going?
Session Chair(s)
Suzanne Schrandt, JD
Founder, Chief Executive Office and Chief Patient Advocate
ExPPect, United States
Measuring the impact of patient engagement efforts is a tool for ensuring meaningful exchange and for driving toward meaningful outcomes. This session presents a frank and forward looking discussion about addressing the constraints around utilizing patient engagement metrics and new initiatives that will help to advance the field.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify challenges and constraints around measuring the impact of patient engagement
- Describe approaches to addressing these challenges and constraints
- Discuss the impact of key initiatives on the use of appropriate metrics to advance patient engagement
Speaker(s)
Patient-Centricity & Ethics in Pharma
Jennifer Miller, PhD
Yale School of Medicine, United States
Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics
Implementing Metrics - Where are We Going?
Theresa Mullin, PhD
FDA, United States
Associate Center Director - Strategic Initiatives, CDER